Peritoneal Cancer

141 clinical trials · Condition

Record	Firm	Date
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT00096993)	Genentech, Inc.	2005-01-01
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer (NCT00461786)	Eli Lilly and Company	2004-09-01
Letrozole in Patients With Ovarian Tumors (NCT00505661)	M.D. Anderson Cancer Center	2003-09-01
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer (NCT00501644)	M.D. Anderson Cancer Center	2003-01-01
Depression Treatment and Screening in Ovarian Cancer Patients (NCT00515372)	M.D. Anderson Cancer Center	2002-12-20
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer (NCT00061308)	GlaxoSmithKline	2002-12-01
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane (NCT02728622)	Nordic Society of Gynaecological Oncology - Clinical Trials Unit	2002-03-01
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer (NCT00055432)	Eli Lilly and Company
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy (NCT00189358)	AGO Study Group

Every clearance here is in the API, with alerts when new ones post.